Results of the procurement procedure
Legal Basis:
This contract will be financed by the European Investment Bank (EIB) and is subject to the EIB's guide to Procurement.
Section I: Contracting authority
I.1)Name and addressesOfficial name: Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia
Postal address: 144 Ak. Tsereteli Avenue
Town: Tbilisi
NUTS code:
GE GeorgiaPostal code: 0119
Country: Georgia
Contact person: Nino Kvernadze
E-mail:
PIU@moh.gov.geTelephone: +995 599184644
Internet address(es): Main address:
https://www.moh.gov.ge/ I.4)Type of the contracting authorityMinistry or any other national or federal authority, including their regional or local subdivisions
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Purchase Contracts for SARS-CoV-2 Vaccine (Vero Cell), Inactivated or COVID-19 Vaccine, Inactivated
Reference number: EIB-GtP/INCO 20160405 28
II.1.2)Main CPV code33651600 Vaccines
II.1.3)Type of contractSupplies
II.1.4)Short description:
Purchase Contracts for SARS-CoV-2 Vaccine (Vero Cell), Inactivated or COVID-19 Vaccine, Inactivated
II.1.6)Information about lotsThis contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)Value excluding VAT: 1.00 USD
II.2)Description
II.2.3)Place of performanceNUTS code: GE Georgia
Main site or place of performance:
144 Ak. Tsereteli Avenue ,Tbilisi, Georgia
II.2.4)Description of the procurement:
Purchase of SARS-CoV-2 Vaccine (Vero Cell), Inactivated or COVID-19 Vaccine, Inactivated
II.2.5)Award criteriaPrice
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
Section IV: Procedure
IV.1)Description
IV.1.1)Type of procedureAward of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below
- Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the directive
Explanation:
During the very acute period of the pandemics, the Government of Georgia made decision to enter into direct bilateral contracts with vaccine manufacturers in order to minimize devastating consequences of the pandemic, reduce COVID-19 related illnesses, hospitalizations and deaths. The only available options to secure required coverage of the population (60% by the end of 2021) based on “Georgia COVID-19 Vaccine National Deployment Plan” approved by the Governmental Resolution #67 as of January 21, 2021, was direct purchase under the COVAX Facility and via manufacturers. Such selection needs approval of the Government, which has been obtained accordingly.
“Interagency Coordination Commission on Introduction of the COVID-19 Vaccination in Georgia” (established under GoG Decree #2459, 15.12.2020) along with Georgia's National Immunization Technical Advisory Group (NITAG), the “Covid-19 Vaccines and Medicines Procurement Coordination Commission” (established under the Ministerial order 01-53/o, 11.02.2021) made decision regarding procurement of eligible vaccines including, SARS-CoV-2 Vaccine (Vero Cell) directly from the manufacturers.
All vaccines that have been purchased by the Promoter are eligible and authorized by WHO Emergency Use Listing (EUL).
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.8)Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice
Section V: Award of contract
Contract No: SPIT21-IMC-HKXG-074
Title:
Purchase of SARS-CoV-2 Vaccine (Vero Cell), Inactivated or COVID-19 Vaccine, Inactivated
A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:18/06/2021
V.2.2)Information about tendersNumber of tenders received: 1
Number of tenders received from tenderers from non-EU Member States: 1
The contract has been awarded to a group of economic operators: yes
V.2.3)Name and address of the contractorOfficial name: China National Biotec Group Company Limited
Postal address: Building 2, B2 Shuangqiao Road, Chaoyang District, Beijing 100024 P.R
Town: Beijing
NUTS code: CN China
Country: China
The contractor is an SME: no
V.2.3)Name and address of the contractorOfficial name: Beijing Institute of Biological Product Co. Ltd
Postal address: No. 6 Boxing 2nd Road, Beijing Economic and technological Development Zone China
Town: Beijing
NUTS code: CN China
Country: China
The contractor is an SME: no
V.2.3)Name and address of the contractorOfficial name: Sinopharm International Hongkong Limited
Postal address: Room 1601, Emperor group centre , 288 hennessy road, Wanchai, Hong Kong
Town: Wanchai, Hong Kong
NUTS code: CN China
Country: China
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)Total value of the contract/lot: 1.00 USD
V.2.5)Information about subcontracting
Section VI: Complementary information
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review bodyOfficial name: China International Economic and Trade Arbitration Commission
Town: Beijing
Country: China
VI.5)Date of dispatch of this notice:30/01/2023